KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) EBIT Margin: 2018-2025

Historic EBIT Margin for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -30.23%.

  • Twist Bioscience's EBIT Margin rose 1232.00% to -30.23% in Q3 2025 from the same period last year, while for Sep 2025 it was -36.18%, marking a year-over-year increase of 3438.00%. This contributed to the annual value of -36.18% for FY2025, which is 3437.00% up from last year.
  • Latest data reveals that Twist Bioscience reported EBIT Margin of -30.23% as of Q3 2025, which was up 3.58% from -31.36% recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's EBIT Margin registered a high of -30.23% during Q3 2025, and its lowest value of -133.13% during Q4 2021.
  • Moreover, its 3-year median value for EBIT Margin was -64.92% (2024), whereas its average is -63.67%.
  • In the last 5 years, Twist Bioscience's EBIT Margin slumped by 3,100bps in 2021 and then soared by 7,780bps in 2025.
  • Quarterly analysis of 5 years shows Twist Bioscience's EBIT Margin stood at -133.13% in 2021, then surged by 5,086bps to -82.28% in 2022, then skyrocketed by 1,657bps to -65.70% in 2023, then skyrocketed by 2,665bps to -39.05% in 2024, then skyrocketed by 1,232bps to -30.23% in 2025.
  • Its EBIT Margin stands at -30.23% for Q3 2025, versus -31.36% for Q2 2025 and -44.79% for Q1 2025.